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Differences in Quality of Life Across Renal Replacement Therapies:
A Meta-Analytic Comparison
Jill l. Cameron, MSc, Catherine Whiteside, MD, PhD, Joel Katz, PhD, and Gerald M. Devins, PhD
o A meta-analysis compared emotional distress and psychological well-being across renal replacement therapies
(RRTs) and examined whether differences could be explained by: (1) treatment modalities, (2) case mix, or (3)
methodologic rigor, Standard meta-analytic procedures were used to evaluate published comparative studies,
Successful renal transplantation was associated with: (1) lower distress (effect size, d = -0.43 SD) and greater
welf-being (d = 0.62 SD) than incenter hemodialysis (CHD) and (2) lower distress (d = -0.29 SD) and greater
well-being (d = 0.53 SD) than continuous ambulatory peritoneal dialysis (CAPD). CAPD was characterized by
greaterwell-being (d = 0.18 SD) than CHD and CHD was associated with greater distress (d = 0.16 SD) than home
hemodialysis. Although methodologic rigor and case-mix differences did not correlate with the magnitude of
psychosocial differences across RRTs, 10 of the 12 comparisons (83%) were threatened by publication bias (ie, that
nonsignificant comparisons may have been underrepresented in the published literature). Thus, although signifi-
cant quality-of-life differences were evident across treatment groups, the types of patients representative of the
various RRTs also differed significantly in terms of case-mix variables relevant to psychosocial well.being and
emotional distress. Published findings indicating differential quality of life across RRTs may thus be attributable to:
(1) valid differences in effective renal replacement, reduced medical complications, and lifestyles afforded by these
treatment modalities; (2) case-mix differences in the patient samples selected to represent them in research
comparisons; or (3) both of these alternative explanations.
INDEXWORDS: Qualityof life; renal replacementtherapy(RRT); meta-analysis; comparativestudies; psychosocial;
case mix.
SUCCESSFUL RENAL transplantation (RT)\J is generally accepted as the preferred treat-
ment for end-stage renal disease (ESRD). Among
all renal replacement therapies (RRTs), success-
ful transplantation most closely replicates the
normal process of waste removal and precludes
known shortcomings of maintenance dialysis (eg,
medical complications, such as hyperparathyroid-
ism and transient azotemia).In addition, it elimi-
nates the constraints imposed by maintenance
dialysis and, as a result, many assert that success-
ful transplantation affords a better quality of
life.r Although this position is supported by a
growing consensus in the published literature,
findings are inconsistent (eg, Bremer et al,2 Evans
et al,3 and Simmons et al4 versus Devins et al5'6
and Johnson et al7).It is also unclear whether this
quality-of-life superiority is due to genuine ben-
efits of the treatrnent or preexisting nontreatment
differences between groups. Patients are not ran-
domly assigned to RRTs and, as a result, treat-
ment groups frequently difter with respect to
many characteristics relevant to quality of life
(eg, age, socioeconomic status, and nonrenal
health).8 Research findings are ambiguous when
investigators do not take such case-mix difter-
ences into consideration.e Other method weak-
nesses that threaten the validity of quality-of-life
comparisons across RRTs include reliance on
samples ofconvenience and the use ofnew and
unvalidated measurement instruments. l0
A comprehensive review of this literature can
establish the extent to which quality of life dif-
fers across alternative RRTs. The traditional ap-
proach to reviewing empirical literature is the
narrative review (eg, De-Nourr I ). Unfortunately,
the breadth and comprehensiveness of narrative
reviews are limited by difficulties inherent in the
challenges of identi$ring and integrating the find-
ings of independent studies, especially when the
question of interest has been studied for many
years and by numerous investigators. Narrative
reviews often focus on a select or nonrepresenta-
tive sample of published articles, potentially re-
flecting the reviewer's unique perspective and/or
biases.12 They typically exclude unpublished stud-
ies, especially those that report statistically non-
significant results (because these are difficult to
locate); non-English-language publications are
often underrepresented; and relevant articles are
often overlooked despite powerful computerized
literature search engines, such as MEDLINE.
Given their impressionistic integration and inter-
pretation of research findings, it is difficult to
evaluate the extent to which the validity of obser-
vations incorporated into a narrative literature
review may have been compromised by extrane-
ous influences (eg, case-mix differences). Fi-
nally, reliance on significance tests to indicate
the reliability of treatment-group differences al-
lows studies with large sample sizes to exert a
disproportionate effect on the interpretation of
results and thus the conclusions reached by the
narrative review.
Meta-analysisl3 provides a quantitatively more
precise research-synthesis strategy that over-
comes many of the weaknesses intrinsic to tradi-
tional narrative reviews. Meta-analysis endeav-
ors to be comprehensive, and reviewers are
encouraged to include all research examining the
question of interest. If limited to published stud-
ies, it is possible that statistically significant
differences may be overrepresented because of
editorial biases to accept only positive findings
(this phenomenon has been labeled "publication
bias"ra). Strategies exist (eg, calculating fail-
safe numbers and tolerance levelsl3'la) to esti-
mate whether and to what extent the validity of
results may be threatened by this problem, and
methodologists have emphasized the need to
incorporate such considerations in the interpreta-
tion of meta-analyses.l2'15 Quantitative effect-
size (ES) estimates facilitate direct comparisons
between studies by standardizing results (eg,
differences between group means) to facilitate
comparisons based on different measurement in-
struments and varying statistical techniques.l3 In
addition, meta-analysis can provide quantitative
estimates of the degree to which study character-
istics may be related to the magnitude of treat-
ment effects, examining, for example, whether
and to what extent differences in research de-
signs, methodologic rigor, or case-mix differ-
ences are related to quality-of-life diflerences be-
tween dialysis patients and transplant recipients.
THE PRESENT STUDY
A meta-analysis was conducted to examine
differences in quality of life across altemative
treatment modalities for ESRD. All published
research comparing RRTs in terms of emotional
distress and/or psychological well-being were
systematically retrieved from the literature. The
analysis was designed to address the following
research questions: Do psychological well-being
and/or emotional distress differ across alterna-
tive RRTs and, if they do, to what extent can
differences be explained bV (1) differences in
case mix across treatment groups or (2) differ-
ences in methodologic rigor across studies?
METHODS
Study Retrieval
Relevant studies were identified through MEDLINE,
PsychINFO, CINAHL, personal reference databases, and
the bibliographies of retrieved articles. Studies were in-
cluded in the analysis if they met the following criteria: (l)
they reported at least one quantitative comparison between
at least two modes of treatment, ie, RT, hospital-based
incenter hemodialysis (CHD), continuous ambulatory perito-
neal dialysis (CAPD), and home hemodialysis (HHD); (2)
included at least one measure ofpsychological well-being or
emotional distress; (3) used a prospective research design,
including repeated-measures, an equivalent-comparison
group, or an independent-comparison group; (4) involved
adult patients (aged >18 years); and (5) reported the infor-
mation necessary to calculate directly or to estimate ESs.
Studies were excluded if they met one or more of the
following criteria: (l) quality of life on one's current mode
of treatment was compared retrospectively with an earlier
modality and no other comparative data were reported, (2)
treatment included something other than conventional RRT
(eg, drug trials or multiorgan transplantation), and (3) data
conceming psychosocial outcomes were provided by some-
one other than the patient (eg, nurse or family member).16
In meta-analysis, data from research participants can only
be included once for each dependent variable. We therefore
evaluated the independence of research samples by review-
ing articles with similar or overlapping investigators to
determine whether the same groups of subjects might have
been used in more than one publication. This was achieved
by determining when, where, and how many subjects were
included in a study. If more than one published article
reported findings based on the same subjects, the articles
were treated as a single study and all the publications in the
series were used to obtain the required information.
Dependent Vqriqbles
TWo complementary psychosocial constructs were exam-
ined to represent quality of life in ESRD: emotional distress
(eg, depression, anxiety, negative affect) and psychological
well-being (eg, life satisfaction, happiness, positive affect).
Current consensus in the psychology ofemotion maintains
that positive and negative affect are statistically independent
and are best represented by distinct unipolar measures.
Consistent with this assertion is that nonoverlapping determi-
nants have been identified for each of these states.6,l7-20
Although positive and negative affect frequently show
complementary patterns of association, their distinctiveness
has been observed in quality-of-life research comparing
altemative RRTs in which dialysis and posttransplantation
patients differed significantly in psychological well-being
but not emotional distress.5'6,2r
Instruments commonly used to measure emotional dis-
tress include the Center for Epidemiologic Studies Depres-
sion Scale,22 the Beck23 Depression Inventory and the Pro-
file of Mood States.2a Common measures of psychological
well-being include the Bradbuml8 Affect Balance Scale, the
Campbell25 Index of Well-Being, and the Canhil26 Ladder
(Life Satisfaction).
Independent Variables
The meta-analysis was designed to investigate the extent
to which emotional distress and psychological well-being
were related to the following independent variables: (1)
mode of RRI (2) case mix, (3) methodologic rigor, and (4)
research design. Case mix refers to preexisting differences
across treatment groups that are independent ofRRT-related
differences (eg, age, sex, education, socioeconomic status,
marital status, physical health, duration of treatment and,/or
illness). Methodologic rigor relates to the validity of the
research method. It was evaluated using an 1 l-item checklist
developed for the present study (eg, use ofvalid and reliable
measurement instruments, use of sampling controls, and
examination of and,/or control for case-mix differences). We
also included the Science or Social Science Citation Index
impact score associated with the scholarly outlet in which
the shrdy was published as a complementary index of
methodologic rigor (this score indicates the fiequency with
which articles published in a particular outlet are cited in
other published papers).
Meta-Analytic Methods
A standardized data extraction protocol obtained all infor-
mation necessary to calculate ESs for each article included
in the meta-analysis. Two independent reviewers evaluated
the precision ofthe data extraction form and obtained.T9%o
agreement. Reliability for each of the items used to indicate
methodologic rigor was very good; r coefficients ranged
from0.82to 1.0.
The random-effects model was the primary statistical
model adopted because study characteristics are not consls-
tent across publications. The fixed-effects model was used to
examine the impact of study characteristics, methodologic
rigor, and case-mix differences on ESs because of the
availability of automated standardized procedures using
conventional statistical computer packages (eg, SPS32? [SSPS
Inc, Chicago, ILI). The two models only differ when there is
a large amount of between-study variability, in which case
the random-effects model takes this variability into consider-
ation and oroduces more conservative results.
ESs were represented by Cohen's d to estimate the stan-
dardized mean difference between treatment groups ex-
pressed in SD units.r3,28r0 Adjusted ESs were calculated to
control for potential overestimation caused by small sample
sizes.28
Because information is not reported uniformly across
studies, we calculated ESs using (1) the standardized mean
difference method, (2) Cohen's d for categorical data, (3)
significance tests, or (4) significance levels. For repeated-
measures and equivalent-group designs, significance tests or
levels were not used to avoid overestimation of the ES.3r
When all the information necessary to calculate an indi-
vidual ES was not available, we calculated an estimate using
standard methods.3o Because each treatment comparison can
contribute only one ES for each dependent variable, ESs
were averaged for sfudies using more than one measure of
the same dependent variable (ie, multivariate measure-
ment).32
Statistical Analyses
We calculated summary ESs and 95olo confidence inter-
vals (CIs) for each dependent variable for which there were
five or more studies comparing particular treatment modali-
ties.13 We calculated fail-safe numbers and tolerance levels
to evaluate the threat ofpublication bias (that studies show-
ing statistically nonsignificant treatment differences may not
have been published), following established methods.ra The
fail-safe number indicates how many unpublished studies
with null results would be necessary to render statistically
significant meta-analytic ESs nonsignificant. The tolerance
level (five times the number of studies included in the
meta-analysis plus l0) is a method of evaluating the strength
of the fail-safe number and is the number of unpublished
studies that might reasonably be expected to exist. Accord-
ing to recognized criteria, the validity of meta-analytic
results is threatened by publication bias whenever the toler-
ance level exceeds the fail-safe number.ra Such circum-
stances leave open the possibility that publication bias
threatens the validity ofmeta-analytic findings because the
plausible number of unpublished negative findings exceeds
the number required to reduce a statistically significant ES to
nonsignificant (this problem has also been referred to as the
file-drawer problem).
We undertook sensitivity analyses33 using weighted analy-
sis of variance and correlation to determine whether ob-
served treatment-group differences were systematically re-
lated to sfudy characteristics, such as case mix, research
design, or methodologic rigor. These analyses were intended
to indicate whether the magnitude of treatment-group differ-
ences were related systematically to characteristics of the
studies, including group differences in case-mix variables.
First, we examined research characteristics (eg, research
design, total sample size, year ofpublication, and method of
ES estimation), common sources of variability,34 to deter-
mine, for example, if one type of research design showed
larger or smaller group differences in the dependent vari-
ables. Second, we examined case-mix differences through
sensitivity analyses that compared ESs across studies in
which the treatment groups differed or did not difler with
respect to each of the case-mix variables. Third, we corre-
lated degree of method rigor with ESs (eg, might larger
group differences be evident in methodologically weaker
studies?).
To facilitate the interpretation of results, we determined
their associated percentile ranks by referring the ES statistic
to the normal distribution. This transformation can be inter-
preted to indicate how highly a person scoring at the median
in one treatment group would rank in the other treatment
group for a given variable.r2
RESULTS
Identification of Published Reports
The literature search strategy identified 3,267
studies published before August 1998, and we
reviewed titles and abstracts to identifu publica-
tions satisffing the inclusion and exclusion crite-
ria. Sixty-one published articles (1 9%) met these
conditions and were included in the meta-
analysis. We excluded publications for the follow-
ing reasons: (1) 2,761 articles (84.5%) did not
measure a psychosocial variable, although they
had quality-of-life implications; (2) 95 articles
(2.9%) did not report new data (eg, literature
reviews, editorials); (3) 61 articles (1.9%) were
drug studies (eg, investigating erythropoietin or
cyclosporine); (9 25 articles (0.8%) involved
children; (5) 25 articles (0.8%) concemed sur-
vival or physical symptoms; (6) 190 articles
(5. 8%) reported psychosocial measurements for
a single or combined treatment group; (7) 13
articles (0.4%) overlapped with another pub-
lished article; and (8) 36 articles (l.l%) were
excluded for a variety of other reasons (eg,
retrospective design).
For studies not providing all the information
necessary to calculate an ES, we contacted the
authors by mail and requested the missing infor-
mation. Of the 44o/o who responded, 4lo/o (or
18% overall) provided additional information.
As a result, it was necessary to exclude 13 of the
6l retrieved studies (21%) from the meta-
analysis because of insufficient information to
estimate ESs. The final number of studies in-
cluded in the analyses was thus 49. This included
77 treatment comparisons involving emotional
distress and 66 involving psychological well-
being.
Treatment Comparisons of Emotional Distress
and P syc ho lo gical Well-B eing
The meta-analytic results for the treatment
comparisons involving emotional distress and
psychological well-being are listed in Tables I
and 2. These tables present random-effects model
summary results for each treatment comparison,
including summary ESs, 95% CIs, percentile
ranks, fail-safe numbers, and tolerance levels to
evaluate the threat of publication bias. ES esti-
mates are significantly different from 0 (indicat
ing a reliable difference between the treatment
groups) if the corresponding 95% CI does not
include 0. The percentile rank indicates how an
individual scoring at the median in one group (ie,
50th percentile) would score were he or she a
member of the other treatment group. For ex-
ample, the corresponding percentile rank for an
ES of 1.0 would be 84, indicating that an indi-
vidual reporting quality of life at the median for
one treatment group would have scored at a level
greater than 84o/o of the patients in the other
group.
Emotional distress. Table I lists the treat-
ment comparisons regarding emotional distress.
Successful renal transplant recipients reported
significantly less emotional distress than patients
undergoing CHD (mean ES : 
-0.43; n : 25;
95oA CI, 
-0.53 to -0.33) and CAPD (mean ES :
Table 1. Summary Results of Treatment Comparisons of Emotional Distress
Comparison
Mean
ES 95% Cl
Percentile
Rank
FaiFSafe
Number
Tolerance
Level
RT vCHD (25)
RT vCAPD (10)
RT vHHD (7)
CAPD vCHD (17)
CAPD vHHD (7)
CHD vHHD (11)
-0.53 to -0.33
-0.55 to -0.03
-0.49 to 0.07
-0.29 to 0.'11
-0.25 to 0.43
0.07 loO.24
-0.43-
-0.29-
-0.21
-0.09
0.09
0.1 6-
tJc
60
45
95
45
b3
79
2
0
0
70
JJ
42
r+o
54
56
NOTE. Number in parentheses indicates number of studies summary results based on.
*Effect sizes signiflcantly different from 0.
Table 2. Summary Results of Treatment Comparisons of Psychological Well-Being
Comparison
Mean
E5 95% Cl
Percentile
Rank
FarF|'are
Number
Tolerance
Level
RT vCHD (16)
RT vCAPD (11)
RT vHHD (7)
CAPD vCHD (18)
CAPD vHHD (7)
CHD vHHD (7)
0.62-
0.53-
0.66
0.1 8"
-0.06
-0.19
0.46 to 0.78
0.30 to 0.76
-0.09 to 1.41
0.07 to 0.28
-0.45 to 0.34
-0.73 to 0.35
201
49
0
28
0
0
73
70
75
57
48
42
90
65
45
100
45
45
NOTE. Number in parentheses indicates number of studies summary results based on.
*Effect sizes significantly different from 0.
-0.29; n : 10; 95yo CI, -0.55 to -0.03). CHD
patients reported significantly more emotional
distress than HHD patients (mean ES : 0.16i
n = l1; 95oA CI,0.07 to 0.24). No other group
comparisons were statistically significant. All
but one of the comparisons, however, may be
threatened by publication bias. Because the toler-
ance level (65) was lower than the fail-safe
mrmber (70), the comparison of CHD versus
HHD may not be threatened by publication bias.
Psychological well-being. Table 2 lists the
treatment comparisons for psychological well-
being. Successful renal transplant recipients re-
ported significantly more psychological well-
being than patients undergoing CHD (mean ES :
0.62; n : 16; 95%o CI,0.46 to 0.78) and CAPD
(mean ES : 0.53; n : 11; 95o CI,0.30 to 0.76).
CAPD patients reported significantly more psy-
chological well-being than CHD patients (mean
ES = 0.18; n : 18; 95oh CI,0.07 to 0.28). No
other significant group differences were ob-
served. As noted for the comparisons involving
emotional distress, however, all but one of the
treatment comparisons were threatened by publi-
cation bias. The fail-safe number (201) exceeded
the tolerance level (90) for the comparison of
renal transplant versus CHD patients.
Sensitivity Analyses
Research charqcteristics. We examined sev-
eral characteristics ofthe published literature to
determine whether study characteristics might be
related systematically to the magnitude of re-
ported results. None of these comparisons, how-
ever, indicated a significant relation between
study characteristics and the magrritude of treat-
ment-group differences in psychosocial out-
comes. Across all studies comparing one or both
dependent variables, the research designs in-
cluded 89 studies (88.1%) with an independent-
group design, 6 studies (5.9%) with equivalent-
or matched-group designs, and 6 studies (5.9%)
with a prospective repeated-measures design.
Results indicated that neither emotional distress
nor psychological well-being ESs differed signifi-
cantly across these three categories. ESs did not
difler significantly whether they were calculated
directly or estimated because of incomplete re-
porting of statistical results. The methodologic
rigor of the study, assessed by the checklist
developed for this analysis and the Citation In-
dex impact score, did not significantly relate to
the ES estimates when examined across all treat-
ment comparisons. Additionally, the total sample
size and year of publication were not signifi-
cantly associated with the ES estimates.
Cose-mix dffirences. Case-mix differences
between treatrnent groups were examined as po-
tential sources ofvariability across ESs. To facili-
tate the sensitivity analyses, case-mix variables
were coded 0 when the treatment comparison did
not significantly differ with respect to the vari-
able, I when they differed significantly, and 2
when the case-mix variable was not assessed.
Sensitivity analyses were conducted to deter-
mine whether ESs varied with respect to the
categorized case-mix treatment-group differ-
ences. Six of the 120 sensitivity analyses (5.8%)
were significant at P less than 0.05, but because
of the very large number of comparisons, these
must be considered skeptically. We conclude,
therefore, that ESs did not vary systematically
across studies depending on whether they dif-
fered with respect to case mix.
These results are limited, however, because of
the relatively small numbers of studies compar-
Table 3, Summary of Differences Between Treatment Groups on Gase-Mix Variables, Emotional Distress
Treatment Comparisons
Comparison*
Physical
lndicators Employment Education
Sex
(men)
RT vCHD (25)
RT vCAPD (10)
RT vHHD (7)
CAPD vCHD (17)
CAPD vHHD (7)
CHD vHHD (11)
-0.3e+ (1e)
-0.88+ (6)
-o.il+ (6)
-0.05 (12)
0.28+ (6)
0.1e (8)
-0.4e+ (14)
-0.46+ (7)
-0.41+ (6)
-0.21+ (10)
0.12 (5)
0.22+ (7)
0.28+ (13)
0.54+ (4)
0.14 (3)
0.16 (8)
-0.58 (2)
-0.26 (3)
0.27f (e)
0.11 (4)
0.66+ (4)
0.23+ (7)
0.07 (4)
-0.37* (5)
0.03 (20)
0.17+ (8)
0.04 (6)
0.07 (15)
-0.12 (6)
-0.11(7)
*Treatment comparison (number of studies examining emotional distress or psychological well-being)
tMean effect sizes (number of studies included in mean).
fMean effect size is significantly different from 0; P < 0.05.
ing RRTs with respect to emotional distress and
psychological well-being (ie, the number of treat-
ment comparisons for each dependent variable
rangedbetweenT and25). Moreover, few studies
provided the information necessary to calculate
ESs for the case-mix variables. Nevertheless.
significant case-mix differences were evident
across the treatment groups. Tables 3 and 4 list
the differences between groups regarding funda-
mental case-mix variables (age, physical indica-
tors, employment status, educational achieve-
ment, and sex). The tables present mean ESs,
their statistical significance, and the number of
studies reporting information for each variable.
In addition to the already reported differences in
psychological well-being and emotional distress,
comparisons between RT and CHD were con-
founded by significant group differences in age,
physical indicators (eg, comorbid conditions, se-
rum electrolyte levels), educational attainment,
and employment status. Transplant recipients
were significantly younger, healthier, more highly
educated, and more likely to be employed than
CHD patients. Similar trends were evident for
other treatment comparisons.
DISCUSSION
The present meta-analysis corroborates the
growing consensus that the potential for a high
quality of life differs across RRTs. Synthesizing
data from 49 published comparative studies, in-
cluding 77 comparisons involving emotional dis-
tress and 66 involving psychological well-being,
renal transplant recipients reported significantly
less emotional distress and more psychological
well-being than patients on either hospital-based
CHD or CAPD. CAPD patients reported more
psychological well-being than those on hospital-
based CHD, and those on CHD reported more
emotional distress than those receiving HHD.
Although meta-analysis strives to be compre-
hensive in integrating available studies, reliance
on published comparisons can render results vul-
nerable to publication bias. This refers to the
general problem that studies showing statisti-
Table 4. Summary of Differences Between Treatment Groups on Case-Mix Variables, Psychological Well-Being
Treatment Comparisons
Comparison*
Physical
Indicators Employment Education
Sex
(men)
RT vCHD (16)
RT vCAPD (11)
RT vHHD (7)
CAPD vCHD (18)
CAPD vHHD (7)
CHD vHHD (7)
-0.73+ (11)
-0.8e+ (6)
-0.68+ (5)
-0.18+ (10)
0.21 (5)
0.21 (5)
-0.55+ (12)
-0.48+ (e)
-0.40f (6)
-0.32 (13)
0.23+ (6)
0.33+ (7)
0.36+ (B)
0.5e+ (5)
0.14 (2)
0.17+ (s)
-0.58+ (2)
-0.3e (2)
0.31+ (4)
0.13 (4)
0.22 (3)
0.27+ (7)
0.04 (3)
-0.25 (3)
0.06 (13)
0.17+ (e)
-0.06 (6)
-0.03 (13)
-0.07 (6)
-0.25+ (6)
*Treatment comparison (number of studies examining emotional distress or psychological well-being).
tMean effect sizes (number of studies included in mean).
f Mean effect size is significantly different from 0; P < 0.05.
cally significant effects are more likely to be
accepted for publication than are those with
nonsignificant results, the file-drawer problem. la
This problem was highlighted with regard to the
literature concerning quality of life across alter-
native RRTs. Fail-safe numbers exceeded toler-
ance levels for four ofsix statistically significant
treatment comparisons. ESs estimated on the
basis of published studies may thus be inflated
because nonsignificant comparisons may have
been underrepresented. As a result, one cannot
definitively rule out the competing hypothesis
that the observed superiority of some RRTs may
be attributable not to valid differences in the
quality of life afforded by a particular treatrnent
modality, but rather to a limitation of the litera-
ture. The number of published quality-of-life
comparisons is insufficient to confirm the prevail-
ing consensus (eg, that successful RT affords a
superior quality of life relative to maintenance
hemodialysis or CAPD).
The inability to control for case-mix differ-
ences across groups presents additional chal-
lenges to the synthesis and interpretation ofthis
literature. As suspected, many key variables dif-
fered significantly across RRT groups. Renal
transplant recipients, for example, were signifi-
cantly younger, healthier, more highly educated,
and more likely to be employed than their coun-
terparts on maintenance dialysis. These differ-
ences were similar in magnitude, moreover, to
the RR-T-associated ESs observed for emotional
distress and psychological well-being. Socioeco-
nomic and other demographic characteristics are
importantly related to quality of life in ESRD
and across physically healthy and chronic dis-
ease populations more generally. Quality-of-life
outcomes in ESRD and other chronic disease
populations are reliably associated with sex,35'36
comorbid illnesses,5'6,e and age.37'38
Two studies, highly regarded for their methodo-
logic rigor,2'3 may help illustrate the points we
have asserted in interpreting the present meta-
analytic results. Both used large sample sizes,
psychometrically sound instruments, and di-
rectly examined the issue of case mix. Bremer et
al2 compared psychological well-being, repre-
sented by measures of positive affect and life
satisfaction, across RRT modalities, reporting
group differences similar to those we have ob-
served based on the lareer literature. Differences
across modalities were muted, howeveq when
statistical analyses controlled for case mix. Al-
though a number of potentially relevant variables
were included (age, sex, race, education, primary
diagnosis, duration of treatment, and comorbid
conditions), employment status and income were
not, despite their importance to psychological
well-being.3e Relevant to the present emphasis
on the explanatory power of such factors, more-
over, is the finding that case-mix variables were
significantly related to psychological well-being.
Comorbid conditions did not differ significantly
across RRT groups in this study, however, and
although the study sample was large (n : 489), it
represented only 54oh of the 903 individuals who
received questionnaires. Finally, the study fo-
cused exclusively on psychological well-being;
thus, the results cannot shed light on cross-
modality differences in emotional distress.
Evans et al3 also measured subjective well-
being and compared this across RRTs, investigat-
ing the extent to which differences might be
attributable to case-mix confounders. Like
Bremer et al,2 the investigators observed statisti-
cally significant differences in psychological well-
being across dialysis and posttransplant patients,
and these persisted after controlling for case-mix
differences. Contrary to the findings of Bremer et
al,2 however, comorbid conditions and previous
transplant failures did not relate systematically to
psychological well-being in this data set. In pre-
senting their results, Evans et al3 cautioned against
extrapolating their findings to the larger ESRD
population because of the nonrepresentativeness
of their sample. This consideration, together with
the inconsistencies between the results of these
two widely respected investigations, indicate that
it would be premature to interpret current find-
ings as definitive or conclusive.
It will be crucial in future research to consider
and control for case-mix differences across RRTs.
One powerful method to minimize the validity
threats introduced by case mix would be to use a
prospective repeated-measures experimental de-
sign in which the same cohort of patients can be
assessed repeatedly and at clinically significant
milestones, such as when a patient switches to a
different RRT modality. A more practical and
less costly method might involve careful identifi-
cation and documentation of relevant case-mix
variables followed by statistical controls, as illus-
trated in many existing published studies.
It will also be crucial, of course, to sample
quality-of-life outcomes representatively, includ-
ing measures ofboth positive and negative states.
To date, few studies have included both types of
instruments. Equally important is the need to
ensure that instruments be psychometrically
sound and theoretically relevant. In addition to
examining comorbid conditions as case-mix con-
founders, it would be important to measure sever-
ity of illness more generally and to investigate
whether this contributes incrementally to quality
of life. This might incorporate effects of ESRD
across organ systems. The ESRD Severity In-
dex,a0 for example, assesses the effects of comor-
bid conditions (eg, systemic lupus erythemato-
sus), nonrenal effects of conditions responsible
for renal failure (eg, hypertension), and compli-
cations of renal failure (eg, congestive heart
failure) and/or treatment side effects (eg, dialysis
access events). Routine inclusion of such a mea-
sure might help provide a more comprehensive
assessment as a context in which to compare
quality of life across altemative RRTs. It might
also be useful to sample cases strategically, limir
ing research participants to those patients for
whom any form of RRT would be equally suir
able.
Progress in meta-analytic synthesis of original
findings can be facilitated by establishing a stan-
dard for reporting relevant case-mix information
across research reports. A common core of indi-
cators described in sufficient detail (eg, means
and SDs for each treatment group) would facili-
tate the investigation of case-mix variables as
important explanatory factors in relation to qual-
ity of life because this may differ across RRTs.
Toward this end, it might be useful for joumals to
standardize policy conceming the types of de-
scriptive data required for publications based on
clinical samples.
This meta-analysis found significant differ-
ences among RRTs with respect to two fundamen-
tal quality-of-life dimensions: psychological well-
being and emotional distress. Although the results
corroborated existing clinical impressions, their
validity was generally threatened by the potential
existence ofunpublished studies showing nonsig-
nificant differences across treatment groups. Va-
liditv was also threatened bv the observation that
important case-mix variables differed across the
treatment groups. Because these variables are
also importantly related to psychosocial out-
comes in ESRD, the existing literature cannot
rule out the competing hypothesis that observed
quality-of-life differences across RRTs are attrib-
utable to preexisting nonrenal and/or nontreat-
ment differences. Research should address the
problem of case mix directly and consistently,
reporting relevant data for each treatment goup
in sufficient detail to facilitate future meta-
analyses. Although the best available evidence to
date indicates that quality of life differs system-
atically across patients receiving alternative RRTs,
it is not clear whether this occurs because of
valid differences across treatment modalities, pre-
existing differences among patients, or a combi-
nation of these two alternatives. We conclude.
therefore, that finther research is required.
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